Optum guides providers through important upcoming formulary updates
Close
Valuable and timely information on drug therapy issues impacting today's health care and pharmacy environment.
March 16, 2020 - The FDA announced the discontinuation of Mylan’s eprosartan tablets due to business reasons.
Download PDF
Return to publications
